Stockscreener 앱 받기
20.77
1.53%
-0.415
전일 마감가:
$21.19
열려 있는:
$20.692
하루 거래량:
181.64K
Relative Volume:
0.19
시가총액:
$630.80M
수익:
$17.16M
순이익/손실:
$-163.62M
주가수익비율:
-3.4169
EPS:
-6.08
순현금흐름:
$-121.61M
1주 성능:
-2.18%
1개월 성능:
+12.72%
6개월 성능:
+4.95%
1년 성능:
-21.50%
1일 변동 폭
$20.17
$20.95
1주일 범위
$20.17
$22.52
52주 변동 폭
$12.21
$41.31
Anaptysbio Inc Stock (ANAB) Company Profile
명칭
Anaptysbio Inc
전화
858-362-6295
주소
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA
ANAB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ANAB
Anaptysbio Inc
|
20.70 | 630.80M | 17.16M | -163.62M | -121.61M | -6.08 |
|
VRTX
Vertex Pharmaceuticals Inc
|
503.09 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
607.22 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
655.28 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
271.20 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.91 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Anaptysbio Inc Stock (ANAB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-04 | 개시 | Wolfe Research | Outperform |
| 2024-12-11 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-12-02 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-07-22 | 개시 | H.C. Wainwright | Buy |
| 2024-07-19 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2024-04-16 | 개시 | Leerink Partners | Outperform |
| 2024-04-11 | 개시 | Wells Fargo | Overweight |
| 2024-03-12 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2024-02-26 | 개시 | BTIG Research | Buy |
| 2024-02-21 | 개시 | Stifel | Buy |
| 2024-02-16 | 개시 | Piper Sandler | Overweight |
| 2023-05-22 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2023-05-18 | 개시 | TD Cowen | Outperform |
| 2023-01-06 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2022-11-01 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2022-09-19 | 재개 | H.C. Wainwright | Buy |
| 2022-09-13 | 다운그레이드 | Truist | Buy → Hold |
| 2022-09-01 | 개시 | Raymond James | Outperform |
| 2022-03-22 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-06-22 | 개시 | H.C. Wainwright | Buy |
| 2021-05-21 | 개시 | UBS | Neutral |
| 2021-03-16 | 업그레이드 | Truist | Hold → Buy |
| 2021-03-09 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2021-03-08 | 다운그레이드 | JP Morgan | Overweight → Underweight |
| 2021-02-11 | 업그레이드 | JP Morgan | Underweight → Overweight |
| 2020-10-27 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2020-10-14 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2019-11-08 | 다운그레이드 | JP Morgan | Overweight → Underweight |
| 2019-11-08 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-11-08 | 다운그레이드 | SunTrust | Buy → Hold |
| 2019-11-08 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2019-06-21 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2019-06-21 | 다운그레이드 | Stifel | Buy → Hold |
| 2018-12-20 | 개시 | H.C. Wainwright | Buy |
| 2018-11-21 | 개시 | JP Morgan | Overweight |
| 2018-07-19 | 개시 | Credit Suisse | Outperform |
| 2018-04-04 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-03-27 | 재확인 | Stifel | Buy |
| 2018-03-06 | 재확인 | Stifel | Buy |
| 2018-02-15 | 재확인 | SunTrust | Buy |
| 2018-01-23 | 재확인 | Credit Suisse | Outperform |
| 2017-11-15 | 개시 | SunTrust | Buy |
| 2017-11-09 | 개시 | Jefferies | Buy |
| 2017-10-11 | 재확인 | RBC Capital Mkts | Outperform |
| 2017-09-15 | 개시 | RBC Capital Mkts | Outperform |
모두보기
Anaptysbio Inc 주식(ANAB)의 최신 뉴스
AnaptysBio, Inc. (NASDAQ:ANAB) Shares Sold by Invesco Ltd. - Defense World
Boxer Capital Management LLC Invests $17.21 Million in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat
Nebula Research & Development LLC Invests $231,000 in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat
First Light Asset Management LLC Has $11.50 Million Stake in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat
AnaptysBio (ANAB) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Wedbush Reaffirms “Outperform” Rating for AnaptysBio (NASDAQ:ANAB) - Defense World
AnaptysBio, Inc. (NASDAQ:ANAB) Shares Purchased by Geode Capital Management LLC - MarketBeat
JPMorgan Chase & Co. Has $1.52 Million Position in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat
AnaptysBio Gears Up For Key Trial Readouts In Rheumatoid Arthritis And Lung Cancer - RTTNews
AnaptysBio (ANAB) Stock Maintains Outperform Rating with $40 Pri - GuruFocus
Alopecia Areata Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Pfizer, Legacy Healthcare, AnaptysBio, Eli Lilly and Company, Incyte Corp - Barchart.com
What is the investor’s view on AnaptysBio Inc (ANAB)? - uspostnews.com
A company insider recently bought 65,184 shares of AnaptysBio Inc [ANAB]. Should You Buy? - knoxdaily.com
AnaptysBio (NASDAQ:ANAB) versus Endonovo Therapeutics (OTCMKTS:ENDVD) Head-To-Head Comparison - Defense World
(ANAB) Investment Analysis and Advice - news.stocktradersdaily.com
Investor’s Delight: AnaptysBio Inc (ANAB) Closes Weak at 18.59, Down -1.90 - DWinneX
Gaining Ground: AnaptysBio Inc (ANAB) Closes Lower at 16.34, Down -0.37 - DWinneX
AnaptysBio, Inc. (NASDAQ:ANAB) Shares Bought by Russell Investments Group Ltd. - Defense World
AnaptysBio, Inc. (NASDAQ:ANAB) Shares Acquired by Geode Capital Management LLC - Defense World
JPMorgan Chase & Co. Raises Holdings in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World
XTX Topco Ltd Buys 19,727 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat
AnaptysBio Inc (ANAB) Stock: A Comprehensive 52-Week Review - investchronicle.com
What was AnaptysBio Inc (ANAB)’s performance in the last session? - uspostnews.com
Gaining Ground: AnaptysBio Inc (ANAB) Closes Lower at 20.42, Down -5.38 - DWinneX
ANAB Stock Sees Surge of Approximately 12.82% in Last Five Days - knoxdaily.com
AnaptysBio, Inc. (NASDAQ:ANAB) Shares Sold by Federated Hermes Inc. - MarketBeat
Vanguard Group Inc. Has $24.41 Million Holdings in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat
AnaptysBio, Inc. (NASDAQ:ANAB) Receives $33.63 Consensus Target Price from Brokerages - MarketBeat
AnaptysBio, Inc. (NASDAQ:ANAB) Shares Sold by Trexquant Investment LP - MarketBeat
Vanguard Group Inc. Increases Stock Holdings in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World
AnaptysBio, Inc. (NASDAQ:ANAB) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
How To Trade (ANAB) - news.stocktradersdaily.com
Psoriasis Market Outlook in the 7MM Through 2034: In-Depth Analysis by Psoriasis Type | DelveInsight - GlobeNewswire Inc.
KLP Kapitalforvaltning AS Purchases New Position in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World
ADAR1 Capital Management LLC Sells 165,419 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat
AnaptysBio, Inc.'s (NASDAQ:ANAB) Price Is Right But Growth Is Lacking After Shares Rocket 30% - simplywall.st
AnaptysBio (NASDAQ:ANAB) Trading 2.5% HigherTime to Buy? - MarketBeat
AnaptysBio, Inc. (NASDAQ:ANAB) Stock Holdings Increased by Swiss National Bank - Defense World
How to Take Advantage of moves in (ANAB) - news.stocktradersdaily.com
AnaptysBio (NASDAQ:ANAB) Shares Gap UpShould You Buy? - MarketBeat
Charles Schwab Investment Management Inc. Acquires 5,733 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World
AnaptysBio (NASDAQ:ANAB) Trading Down 4.1%Should You Sell? - MarketBeat
AnaptysBio (NASDAQ:ANAB) to Repurchase $75.00 million in Stock - MarketBeat
Anaptysbio Inc (ANAB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Anaptysbio Inc 주식 (ANAB) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| EcoR1 Capital, LLC | Director |
Dec 30 '24 |
Buy |
12.92 |
65,184 |
842,060 |
7,860,180 |
| EcoR1 Capital, LLC | Director |
Dec 31 '24 |
Buy |
12.93 |
13,268 |
171,513 |
7,873,448 |
| EcoR1 Capital, LLC | Director |
Jan 02 '25 |
Buy |
12.95 |
6,646 |
86,070 |
7,880,094 |
| RENTON HOLLINGS | Director |
Nov 29 '24 |
Option Exercise |
6.93 |
10,000 |
69,300 |
11,950 |
| RENTON HOLLINGS | Director |
Nov 29 '24 |
Sale |
25.00 |
10,000 |
250,000 |
1,950 |
0.27%
0.30%
자본화:
|
볼륨(24시간):